Cleared Traditional

K971658 - MOUSE LIVER KIDNEY STOMACH DIAGNOSTIC TEST KIT

K971658 is an FDA 510(k) clearance for MOUSE LIVER KIDNEY STOMACH DIAGNOSTIC T..., manufactured by Jay H. Geller. The device is a Class 2 Immunology device with product code DBL cleared through the Traditional 510(k) pathway after a 39-day FDA review.

K971658 · Jay H. Geller · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1997
Decision
39d
Days
Class 2
Risk

K971658 is an FDA 510(k) clearance for the MOUSE LIVER KIDNEY STOMACH DIAGNOSTIC TEST KIT. Classified as Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control (product code DBL), Class II - Special Controls.

Submitted by Jay H. Geller (Santa Monica, US). The FDA issued a Cleared decision on May 23, 1997 after a review of 39 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5660 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Jay H. Geller devices

FDA 510(k) Submission Details - K971658

510(k) Number K971658 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 14, 1997
Decision Date May 23, 1997
Days to Decision 39 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
66d faster than avg
Panel avg: 105d · This submission: 39d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DBL Device Classification - Class 2, Special Controls

Product Code DBL Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5660
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DBL Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control

All 17
Devices cleared under the same product code (DBL) and FDA review panel - the closest regulatory comparables to K971658.
NOVA LITE ENDOMYSIAL
K980312 · Inova Diagnostics, Inc. · Apr 1998
WIELISA ANTI-GBM TEST SYSTEM
K974169 · Wieslab AB · Feb 1998
IMMUNOSCAN ANTI-GBM QUANTITATIVE KIT
K971464 · Euro-Diagnostica AB · Oct 1997
DIASTAT ANTI-GLOMERULAR BASEMENT MEMBRANE KIT
K963525 · Shield Diagnostics, Ltd. · Nov 1996
RIT LIVER, KIDNEY, STOMACH IFA KIT
K955431 · The Binding Site, Ltd. · Apr 1996
ANTI-NUCLEAR ANTIBODY(ANA) TEST KIT W/MOUSE LIVER
K944191 · Light Diagnostics · Mar 1995